2seventy bio Inc. (TSVT) NASDAQ
$5.50 0.12 (2.23%)
Market Cap: $276.05M
As of 03/28/24 03:13 PM EDT. Market open.
2seventy bio Inc. (TSVT)
NASDAQ
$5.50
0.12 (2.23%)
Market Cap: $276.05M
As of 03/28/24 03:13 PM EDT. Market open.
we are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. with a deep understanding of cancer cell metabolism, genomics, and the human ... read more
we are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. with a deep understanding of cancer cell metabolism, genomics, and the human body’s immune response to tumor cells, we’re applying this knowledge and expertise to new classes of cellular therapies that are designed to “think” smarter and faster than cancer. it is this mindset that propels us forward because we know that time matters -- every day, every minute, every second -- to people living with cancer read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Casdin Capital, LLC | Director | Mar 25, 2024 | Buy | $5.07 | 330,000 | 1,673,991 | 1,960,000 | Mar 25, 2024, 09:44 PM |
Casdin Capital, LLC | Director | Mar 22, 2024 | Buy | $5.12 | 147,377 | 754,069 | 1,630,000 | Mar 25, 2024, 09:44 PM |
Casdin Capital, LLC | Director | Mar 21, 2024 | Buy | $4.90 | 300,000 | 1,470,990 | 1,482,623 | Mar 25, 2024, 09:44 PM |
Baird William D III | Chief Operating Officer | Jan 05, 2024 | Sale | $3.75 | 1,380 | 5,180 | 161,335 | Jan 09, 2024, 04:09 PM |
Gregory Philip D | Chief Scientific Officer | Jan 05, 2024 | Sale | $3.75 | 795 | 2,984 | 230,842 | Jan 09, 2024, 04:09 PM |
Leschly Nick | President and CEO | Jan 05, 2024 | Sale | $3.75 | 1,554 | 5,833 | 1,085,476 | Jan 09, 2024, 04:08 PM |
Leschly Nick | President and CEO | Jan 03, 2024 | Sale | $3.87 | 72,312 | 279,739 | 1,087,030 | Jan 05, 2024, 04:30 PM |
Gregory Philip D | Chief Scientific Officer | Jan 03, 2024 | Sale | $3.87 | 25,613 | 99,084 | 231,637 | Jan 05, 2024, 04:30 PM |
Baird William D III | Chief Operating Officer | Jan 03, 2024 | Sale | $3.87 | 33,651 | 130,179 | 162,715 | Jan 05, 2024, 04:29 PM |
Leschly Nick | President and CEO | Aug 22, 2023 | Sale | $5.49 | 9,312 | 51,090 | 1,159,342 | Aug 24, 2023, 05:04 PM |
Gregory Philip D | Chief Scientific Officer | Aug 22, 2023 | Sale | $5.49 | 6,159 | 33,791 | 257,250 | Aug 24, 2023, 05:04 PM |
Baird William D III | Chief Financial Officer | Aug 22, 2023 | Sale | $5.49 | 7,031 | 38,576 | 196,366 | Aug 24, 2023, 05:04 PM |
Kynam Global Healthcare Master Fund, LP | 10% Owner | Aug 10, 2023 | Buy | $5.96 | 86,414 | 515,027 | 5,142,111 | Aug 16, 2023, 07:11 PM |
Kynam Global Healthcare Master Fund, LP | 10% Owner | Aug 10, 2023 | Buy | $5.92 | 515,414 | 3,049,287 | 5,953,825 | Aug 16, 2023, 07:11 PM |
Kynam Capital Management, LP | 10% Owner | Aug 10, 2023 | Buy | $5.96 | 86,414 | 515,027 | 5,142,111 | Aug 14, 2023, 08:51 PM |
Kynam Capital Management, LP | 10% Owner | Aug 10, 2023 | Buy | $5.92 | 515,414 | 3,049,287 | 5,953,825 | Aug 14, 2023, 08:51 PM |
Leschly Nick | President and CEO | Aug 03, 2023 | Sale | $6.13 | 9,060 | 55,499 | 1,168,654 | Aug 07, 2023, 04:07 PM |
Gregory Philip D | Chief Scientific Officer | Aug 03, 2023 | Sale | $6.13 | 3,966 | 24,295 | 263,409 | Aug 07, 2023, 04:06 PM |
Baird William D III | Chief Financial Officer | Aug 03, 2023 | Sale | $6.13 | 6,906 | 42,304 | 203,397 | Aug 07, 2023, 04:06 PM |
Baird William D III | Chief Financial Officer | Feb 13, 2023 | Sale | $12.86 | 637 | 8,192 | 210,303 | Feb 15, 2023, 05:56 PM |
Heffron Nicola | Chief Operating Officer | Feb 07, 2023 | Sale | $14.70 | 60 | 882 | 89,182 | Feb 09, 2023, 04:32 PM |
Gregory Philip D | Chief Scientific Officer | Jan 11, 2023 | Sale | $10.63 | 1,076 | 11,436 | 99,518 | Jan 18, 2023, 05:18 PM |
Heffron Nicola | Chief Operating Officer | Jan 11, 2023 | Sale | $10.63 | 128 | 1,360 | 89,242 | Jan 18, 2023, 05:18 PM |
Leschly Nick | President and CEO | Jan 11, 2023 | Sale | $10.63 | 2,026 | 21,533 | 534,393 | Jan 18, 2023, 05:18 PM |
Baird William D III | Chief Financial Officer | Jan 11, 2023 | Sale | $10.63 | 1,077 | 11,446 | 78,797 | Jan 18, 2023, 05:18 PM |
Leschly Nick | President and CEO | Jan 12, 2023 | Sale | $10.46 | 6,587 | 68,889 | 536,419 | Jan 17, 2023, 04:30 PM |
Heffron Nicola | Chief Operating Officer | Jan 09, 2023 | Sale | $10.33 | 584 | 6,035 | 89,370 | Jan 11, 2023, 04:24 PM |
Gregory Philip D | Chief Scientific Officer | Jan 09, 2023 | Sale | $10.33 | 3,794 | 39,210 | 100,594 | Jan 11, 2023, 04:23 PM |
Baird William D III | Chief Financial Officer | Jan 09, 2023 | Sale | $10.33 | 3,222 | 33,298 | 79,874 | Jan 11, 2023, 04:23 PM |
Leschly Nick | President and CEO | Jan 09, 2023 | Sale | $10.33 | 2,979 | 30,787 | 543,006 | Jan 11, 2023, 04:23 PM |
Heffron Nicola | Chief Operating Officer | Dec 05, 2022 | Sale | $15.43 | 272 | 4,198 | 89,954 | Dec 06, 2022, 04:47 PM |
Heffron Nicola | Chief Operating Officer | Nov 21, 2022 | Sale | $13.97 | 7,697 | 107,527 | 90,226 | Nov 23, 2022, 04:26 PM |
Baird William D III | Chief Financial Officer | Aug 05, 2022 | Sale | $16.23 | 4,152 | 67,397 | 83,096 | Aug 08, 2022, 05:08 PM |
Gregory Philip D | Chief Scientific Officer | Aug 05, 2022 | Sale | $16.23 | 2,407 | 39,072 | 104,388 | Aug 08, 2022, 05:08 PM |
Leschly Nick | President and CEO | Aug 05, 2022 | Sale | $16.23 | 5,499 | 89,263 | 545,985 | Aug 08, 2022, 05:08 PM |
Baird William D III | Chief Financial Officer | Jul 15, 2022 | Sale | $13.81 | 4,080 | 56,344 | 87,248 | Jul 19, 2022, 04:22 PM |
Gregory Philip D | Chief Scientific Officer | Jul 15, 2022 | Sale | $13.81 | 2,365 | 32,660 | 106,795 | Jul 19, 2022, 04:22 PM |
Leschly Nick | President and CEO | Jul 15, 2022 | Sale | $13.81 | 5,404 | 74,629 | 551,484 | Jul 19, 2022, 04:22 PM |
Leschly Nick | President and CEO | Mar 17, 2022 | Buy | $12.20 | 368,857 | 4,500,055 | 556,888 | Mar 22, 2022, 04:55 PM |
Leschly Nick | President and CEO | Mar 17, 2022 | Option Exercise | $12.20 | 368,857 | 4,500,055 | 556,888 | Mar 21, 2022, 05:07 PM |
Baird William D III | Chief Financial Officer | Feb 17, 2022 | Sale | $14.78 | 427 | 6,311 | 57,578 | Feb 22, 2022, 04:08 PM |
Heffron Nicola | Chief Operating Officer | Feb 07, 2022 | Sale | $16.01 | 1,636 | 26,194 | 55,423 | Feb 08, 2022, 04:34 PM |
Heffron Nicola | Chief Operating Officer | Feb 04, 2022 | Sale | $15.41 | 467 | 7,198 | 57,059 | Feb 08, 2022, 04:34 PM |
Baird William D III | Chief Financial Officer | Jan 07, 2022 | Sale | $23.91 | 896 | 21,421 | 58,005 | Jan 11, 2022, 05:33 PM |
Gregory Philip D | Chief Scientific Officer | Jan 07, 2022 | Sale | $23.91 | 1,452 | 34,714 | 61,660 | Jan 11, 2022, 05:33 PM |
Leschly Nick | President and CEO | Jan 07, 2022 | Sale | $23.91 | 3,270 | 78,179 | 188,031 | Jan 11, 2022, 05:32 PM |
Heffron Nicola | Chief Operating Officer | Dec 07, 2021 | Sale | $31.06 | 257 | 7,983 | 57,526 | Dec 09, 2021, 04:52 PM |
Owner | Relationship | Date | Value($) |
Casdin Capital, LLC | Director | 03/25/2024 | 1,673,991 |
Casdin Capital, LLC | Director | 03/22/2024 | 754,069 |
Casdin Capital, LLC | Director | 03/21/2024 | 1,470,990 |
Baird William D III | Chief Operating Officer | 01/05/2024 | 5,180 |
Gregory Philip D | Chief Scientific Officer | 01/05/2024 | 2,984 |
Leschly Nick | President and CEO | 01/05/2024 | 5,833 |
Leschly Nick | President and CEO | 01/03/2024 | 279,739 |
Gregory Philip D | Chief Scientific Officer | 01/03/2024 | 99,084 |
Baird William D III | Chief Operating Officer | 01/03/2024 | 130,179 |
Leschly Nick | President and CEO | 08/22/2023 | 51,090 |
Gregory Philip D | Chief Scientific Officer | 08/22/2023 | 33,791 |
Baird William D III | Chief Financial Officer | 08/22/2023 | 38,576 |
Kynam Global Healthcare Master Fund, LP | 10% Owner | 08/10/2023 | 515,027 |
Kynam Global Healthcare Master Fund, LP | 10% Owner | 08/10/2023 | 3,049,287 |
Kynam Capital Management, LP | 10% Owner | 08/10/2023 | 515,027 |
Kynam Capital Management, LP | 10% Owner | 08/10/2023 | 3,049,287 |
Leschly Nick | President and CEO | 08/03/2023 | 55,499 |
Gregory Philip D | Chief Scientific Officer | 08/03/2023 | 24,295 |
Baird William D III | Chief Financial Officer | 08/03/2023 | 42,304 |
Baird William D III | Chief Financial Officer | 02/13/2023 | 8,192 |
Heffron Nicola | Chief Operating Officer | 02/07/2023 | 882 |
Gregory Philip D | Chief Scientific Officer | 01/11/2023 | 11,436 |
Heffron Nicola | Chief Operating Officer | 01/11/2023 | 1,360 |
Leschly Nick | President and CEO | 01/11/2023 | 21,533 |
Baird William D III | Chief Financial Officer | 01/11/2023 | 11,446 |
Leschly Nick | President and CEO | 01/12/2023 | 68,889 |
Heffron Nicola | Chief Operating Officer | 01/09/2023 | 6,035 |
Gregory Philip D | Chief Scientific Officer | 01/09/2023 | 39,210 |
Baird William D III | Chief Financial Officer | 01/09/2023 | 33,298 |
Leschly Nick | President and CEO | 01/09/2023 | 30,787 |
Heffron Nicola | Chief Operating Officer | 12/05/2022 | 4,198 |
Heffron Nicola | Chief Operating Officer | 11/21/2022 | 107,527 |
Baird William D III | Chief Financial Officer | 08/05/2022 | 67,397 |
Gregory Philip D | Chief Scientific Officer | 08/05/2022 | 39,072 |
Leschly Nick | President and CEO | 08/05/2022 | 89,263 |
Baird William D III | Chief Financial Officer | 07/15/2022 | 56,344 |
Gregory Philip D | Chief Scientific Officer | 07/15/2022 | 32,660 |
Leschly Nick | President and CEO | 07/15/2022 | 74,629 |
Leschly Nick | President and CEO | 03/17/2022 | 4,500,055 |
Leschly Nick | President and CEO | 03/17/2022 | 4,500,055 |
Baird William D III | Chief Financial Officer | 02/17/2022 | 6,311 |
Heffron Nicola | Chief Operating Officer | 02/07/2022 | 26,194 |
Heffron Nicola | Chief Operating Officer | 02/04/2022 | 7,198 |
Baird William D III | Chief Financial Officer | 01/07/2022 | 21,421 |
Gregory Philip D | Chief Scientific Officer | 01/07/2022 | 34,714 |
Leschly Nick | President and CEO | 01/07/2022 | 78,179 |
Heffron Nicola | Chief Operating Officer | 12/07/2021 | 7,983 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,911,724 | 0.00043% | -11.42% | Other |
BAKER BROS. ADVISORS LP | 2,497,526 | 0.12% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,088,867 | 0.00049% | 4.16% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 636,787 | 0.00509% | Exited | Event Driven |
AQR CAPITAL MANAGEMENT LLC | 323,816 | 0.0026% | 8.36% | Other |
RENAISSANCE TECHNOLOGIES LLC | 98,839 | 0.00066% | Exited | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View